# Construction Partners, Inc. (ROAD) — delisting/forced [announced]
Source: SEC API (secapi.ai) · situation sit_3ae7de9500a5b88a78b0 · retrieved 2026-08-14T01:25:44.751Z

## Overview
Construction Partners, Inc. is a vertically integrated civil infrastructure company operating in local markets throughout the Sunbelt in Alabama, Florida, Georgia, North Carolina, Oklahoma, South Carolina, Tennessee and Texas, focused on the construction, repair and maintenance of surface infrastructure supported by hot-mix asphalt plants, aggregate facilities and liquid asphalt terminals.

Construction Partners, Inc. notified Nasdaq on August 10, 2026, that following the death of independent director Michael H. McKay on July 22, 2026, the company's Audit Committee was reduced to two independent directors, falling below the Nasdaq Listing Rule 5605(c)(2)(A) requirement of a minimum of three independent directors. The company is relying on the cure period under Nasdaq Listing Rule 5605(c)(4)(B) to reestablish compliance, with the cure period ending on the earlier of the company's next annual meeting of stockholders or July 22, 2027. The Board intends to identify and select a new independent director to regain compliance within this cure period.

## Terms
- Counterparty: The Nasdaq Stock Market LLC

## Key dates
- Announced 2026-08-10 · Expiry 2027-07-22 · Expected close 2027-07-22

## Timeline
- 2026-08-10 · 8-K (0001628280-26-055282): 8-K - Construction Partners, Inc. — *Construction Partners, Inc. is a vertically integrated civil infrastructure company operating in local markets throughout the Sunbelt in Alabama, Florida, Georgia, North Carolina, Oklahoma, South Carolina, Tennessee and Texas, focused on the construction, repair and maintenance of surface infrastructure supported by hot-mix asphalt plants, aggregate facilities and liquid asphalt terminals.* Construction Partners, Inc. notified Nasdaq on August 10, 2026, that following the death of independent director Michael H. McKay on July 22, 2026, the company's Audit Committee was reduced to two independent directors, falling below the Nasdaq Listing Rule 5605(c)(2)(A) requirement of a minimum of three independent directors. The company is relying on the cure period under Nasdaq Listing Rule 5605(c)(4)(B) to reestablish compliance, with the cure period ending on the earlier of the company's next annual meeting of stockholders or July 22, 2027. The Board intends to identify and select a new independent director to regain compliance within this cure period.
  https://www.sec.gov/Archives/edgar/data/1718227/0001628280-26-055282.txt

## Citations
- 0001628280-26-055282 — https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&type=&dateb=&owner=include&count=40&search_text=000162828026055282